CRISPR-based microfluidic platform detects respiratory virus

CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants

Researchers in the US have developed a novel multiplexed diagnostic platform based on CRISPR-based approaches and microfluidics - enabling robust and simultaneous surveillance of multiple viruses and viral variants. Currently, the paper is available on the medRxiv* preprint server pending peer review.

Related Keywords

, Yurchanka Siarhei Shutterstock , Broad Institute , Drug Administration , Image Credit , Yurchanka Siarhei , Crispr , Espiratory , Cars , Ars Cov 2 , Essay , Cas13 , Clinical Testing , Coronavirus , Iagnostic , Iagnostics , Na , Luorescence , Microfluidics , Pandemic , Respiratory Virus , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Ranscription , Virus ,

© 2025 Vimarsana